sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Middle East Low Molecular Weight Heparin Market Scope And Analysis

  • Report Code : TIPRE00029731
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 216
Buy Now

Middle East Low Molecular Weight Heparin Market Analysis Report 2022 to 2028

Buy Now

Middle East Low Molecular Weight Heparin Market Report Middle East Low Molecular Weight Heparin Market Size and Share Middle East Low Molecular Weight Heparin Market Scope and Analysis

Middle East Low Molecular Weight Heparin Market Report Scope

Report Attribute Details
Market size in 2021 US$ 151.15 Million
Market Size by 2028 US$ 209.60 Million
Global CAGR (2022 - 2028) 4.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Enoxaparin
  • Dalteparin
  • Tinzaparin
  • Fraxiparine
  • Nadroparin
By Packaging
  • Multi-Vials and Pre-Filled Syringes
By Application
  • Deep Vein Thrombosis
  • Acute Coronary Syndrome
  • Pulmonary Embolism
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Teva Pharmaceutical Industries Ltd
  • Abbott Laboratories
  • Novartis AG
  • Sanofi
  • Pfizer Inc
  • B Braun SE
  • Dr Reddy s Laboratories
  • LEO Pharma A S
  • Aspen Holdings